Gestationsbedingte Trophoblasterkrankungen

L.-C. Horn; S. Ackermann; M. W. Beckmann; J. Einenkel

doi:10.1055/s-2004-820852

Geburtshilfe und Frauenheilkunde, Table of Contents

Geburtshilfe Frauenheilkd 2003; 63(10): R205-R228
DOI: 10.1055/s-2004-820852

GebFra-Refresher

Georg Thieme Verlag Stuttgart · New York

Gestationsbedingte Trophoblasterkrankungen

L.-C. Horn¹ , S. Ackermann² , M. W. Beckmann² , J. Einenkel³

¹Institut für Pathologie und Gynäkologie, Universität Leipzig
²Universitäts-Frauenklinik Erlangen
³Universitäts-Frauenklinik Leipzig

Abstract

Full Text

References

Literatur

1 Scully R E, Bonfiglio T A, Kurman R J, Silverberg S G, Wilkinson E J. WHO - Histological Typing of Female Genital Tract Tumours. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest; Springer 1994
2 Ngan H YS, Odicino F, Maisonneuve P, Beller U, Benedt J L, Heintz A PM, Pecorelli S, Siderei M, Creasman W T. Gestational trophoblastic disease. J Epidemiol Biostat. 2001; 6 177-184
3 DiCintio E, Parazzini F, Rosa C, Chatenoud L, Benzi G. The epidemiology of gestational trophoblastic disease. Gen Diagn Pathol. 1997; 143 103-108
4 Kim S J, Bae S N, Kim J H, Kim C J, Han K T, Chung J K, Lee J M. Epidemiology and time trends of gestational trophoblastic disease in Korea. Int J Gynaecol Obstet. 1998; 60 (Suppl 1) S33-38
5 Kohorn E I. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assesssment. Int J Gynecol Cancer. 2001; 11 73-77
6 Horn L C, Rosenkranz M, Bilek K. Wertigkeit der Plazentahistologie für die Erkennung genetisch bedingter Aborte. Z Geburtsh Perinatol. 1991; 195 47-53
7 Horn L C, Emmrich P, Bilek K, Bruder E. Der frühe plazentare Trophoblast: II. Tumorförmige Störungen der trophoblastären Entwicklung. Zentralbl Gynäkol. 1996; 118 591-597
8 Seckl M J, Fisher R A, Salerno G, Rees H, Paradinas F J, Foskett M, Newlands E S. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000; 356 1443-1444
9 Bilek K, Horn L C, Abu Hmeidan F, Pretzsch G. Gestationsbedingte Trophoblasterkrankungen - Ergebnisse der Jahre 1976 - 1992. Geburtsh Frauenheilk. 1994; 54 519-523
10 Fox H. Differential diagnosis of hydatidiform mole. Gen Diagn Pathol. 1997; 143 117-125
11 Kashimura Y, Kashimura M, Masamichi K, Sugimori H, Tsukamoto N, Matsuyama T, Matsukama K, Kamora T, Saito T, Kawano H, Nose R. Prophylactic chemotherapy for hydatidiform mole. Cancer. 1986; 58 624-629
12 Seckl M J, Newlands E S. Treatment of gestational trophoblastic disease. Gen Diagn Pathol. 1997; 143 159-171
13 Lan Z, Hongzaho S, Xiuyu Y, Yang X. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: A clinical report of 22 patients. Gynecol Oncol. 2001; 83 146-148
14 Lorigan P C, Sharma S, Bright N, Coleman R E, Hancock B W. Characteristics of women with recurrent molar pregnancies. Gynecol Oncol. 2000; 78 288-292
15 Kim J H, Park D C, Bae S N, Namkoong S E, Kim S J. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol. 1998; 71 108-112
16 Garner E IO, Lipson E, Bernstein M R, Goldstein D P, Berkowitz R S. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 2002; 47 380-386
17 Shih I M, Kurman R J. Epitheloid trophoblastic tumor - a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998; 22 1393-1403
18 Davis G A, Survit E A, Garay J P, Fortier J J. Sex assignment in gestational trophoblastic neoplasia. Am J Obstet Gynecol. 1984; 148 722-725
19 Herbst H, Horn L C, Löning T. Trophoblasterkrankungen und Trophoblasttumoren. Pathologe. 1999; 20 72-81
20 Bischoff P, Martelli M. Current topic: Proteolysis in the penetration phase of the implantation process. Placenta. 1992; 13 17-24
21 Shih I M, Kurman R J. Molecular basis of gestational trophoblastic diseases. Curr Mol Med. 2002; 2 1-12
22 Baergen R N. Gestational choriocarcinoma. Gen Diagn Pathol. 1997; 143 127-141
23 Fox H, Laurini R N. Intraplacental choriocarcinoma: A report of two cases. J Clin Pathol. 1988; 41 1085-1088
24 Horn L C, Bilek K. Histologic classification and staging of gestational trophoblastic disease. Gen Diagn Pathol. 1997; 143 87-101
25 Baergen R N, Rutgers J L. Trophoblastic lesions of the placantal site. Gen Diagn Pathol. 1997; 143 143-158
26 Huettner P C, Gersell D J. Placental site nodule: A clinicopathologic study of 38 cases. Int J Gynecol Pathol. 1994; 13 191-198
27 Shih I M, Seidman J D, Kurman R J. Placental site nodule and characterisation of distinctive types of intermediate trophoblast. Hum Pathol. 1999; 30 687-694
28 Shih I M, Kurman R J. The pathology of the intermediate trophoblastic tumors and tumorlike lesions. Int J Gynecol Pathol. 2001; 20 31-47
29 Hui P, Parkash V, Perkins A S, Carcangiu M L. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Invest. 2000; 80 965-972
30 Newlands E S, Mulholland P J, Holden L, Seckl M J, Rustin G J. Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophpsphamide and vicncristine chemotherapy and patients representing with metastatic placental site trophoblastic tumors. J Clin Oncol. 2000; 18 854-859
31 Papadopoulos A J, Foskett M, Seckl M J, McNeish I, Paradinas F J, Rees H, Newlands E S. Twenty-five year's clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002; 47 460-464
32 Denny L A, Dehaeck K, Nevin J, Soeters R, van Wuk A L, Megevand E, Block B. Placental site trophoblastic tumor: Three case reports and literature review. Gynecol Oncol. 1995; 59 300-303
33 Wittekind C, Wagner G. TNM-Klassifikation maligner Tumoren. 5. Aufl. Berlin, Heidelberg, New York; Springer 1997
34 Schmidt D, Baijka M, Köchli O, Robbiani M, Stallmach T. Plazentabett-Tumor: Morphologie, Differentialdiagnose und Prognose. Pathologe. 1995; 16 315-320
35 Hammond C B, Borchert L G, Tyrey L. et al . Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol. 1973; 115 4-8
36 Lurain J R, Brewer Treatment of high-risk gestational trophoblastic disease with methotrexate J I, actinomycin D. and cyclophosphamide chemotherapy . . Obstet Gynecol. 1985; 65 830-836
37 Curry S L, Blessing J A, DiSaia P J, Soper J T, Twiggs L B. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in “poor prognosis” metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Obstet Gynecol. 1989; 73 357-362
38 Newlands E S, Bagshawe K D, Begent R H, Rustin G J, Holden L, Dent J. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979 - 1984). Br J Obstet Gynaecol. 1986; 93 63-69
39 Wong L C, Choo Y C, Ma H K. Modified Bagshawe's regimen in high-risk gestational trophoblastic disease. Gynecol Oncol. 1986; 23 87-93
40 Bolis G, Bonazzi C, Landoni F, Mangili G, Vergadoro F, Zanaboni F, Mangioni C. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol. 1988 Nov; 31 439-444
41 Schink J C, Singh D K, Rademaker A W, Miller D S, Lurain J R. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol. 1992; 80 817-820
42 Soper J T, Evans A C, Conaway M R, Clarke-Pearson D L, Berchuck A, Hammond C B. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol. 1994; 84 969-973
43 Surwit E A, Childers J M. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen. J Reprod Med. 1991; 36 45-48
44 Bagshawe K D, Dent J, Newlands E S, Begent R H, Rustin G J. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumors. Brit J Obstet Gynaecol. 1989; 96 795-802
45 McNeish I A, Strickland S, Holden L, Rustin G J, Foskett M, Seckl M J, Newlands E S. Low-risk peristent gestational trophoblastic disaese: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol. 2002; 20 838-844
46 Roberts J P, Lurain J R. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol. 1996; 174 1917-1923
47 Berkowitz R S, Goldstein D P. Gestational trophoblastic disease. Cancer. 1995; 76: (Suppl 10) 2079-2085
48 Lurain J R. Treatment of gestational trophoblastic tumors. Curr Treat Options Oncol. 2002; 3 113-124
49 Dobson L S, Lorigan P C, Coleman R E, Hancock B W. Persistent gestational trophoblastic disease: Results of MEA (methotrexate, etoposide and dactinomycine) as first-line chemotherapy in hight risk disease and EA (etoposide and dactinomycine) as second-line therapy for low risk disease. Brit J Cancer. 2000; 82 1547-1552
50 Bower M, Paradinas F J, Fisher R A, Nicholson S K, Rustin G J, Begent R H, Bagshawe K D, Newlands E S. Placental site trophoblastic tumor: Molecular analysis and clinical experience. Clin Cancer Res. 1996; 2 897-902